Home/News/REGULATIONREGULATION NewsFDA Issues Updated 2026 Regulatory Framework for AI and Machine Learning in Drug and Biologics SubmissionsThe US Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) and CBER published updated 2026 risk-based credibility assessment guidelines for AI/ML models used in IND and BLA submissions.